Bioventus (BVS) Shares Outstanding (2021 - 2026)

Bioventus (BVS) has 6 years of Shares Outstanding data on file, last reported at $67.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 2.13% year-over-year to $67.6 million; the trailing twelve-month figure through Mar 2026 stood at $67.6 million (up 2.13% YoY), and the FY2025 full-year result was $67.1 million, up 325.03% from the prior year.
• Shares Outstanding for Q1 2026 stood at $67.6 million, up from $67.1 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $67.6 million in Q1 2026 and bottomed at $15.8 million in Q4 2022.
• The 5-year median for Shares Outstanding is $63.0 million (2023), against an average of $55.6 million.
• The widest annual swing landed in 2024, when Shares Outstanding slumped 75.05%; it then soared 325.03% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $15.8 million in 2022, then jumped by 300.76% to $63.3 million in 2023, then plunged by 75.05% to $15.8 million in 2024, then jumped by 325.03% to $67.1 million in 2025, then rose by 0.81% to $67.6 million in 2026.
• The last three Shares Outstanding figures came in at $67.6 million (Q1 2026), $67.1 million (Q4 2025), and $67.0 million (Q3 2025), per Business Quant data.

Peer Comparison